Differentiation of the midbrain dopaminergic pathways during mouse development

Journal of Comparative Neurology

Volumn 476, Issue 3, 2004, Pages 301-311

  Hu, Zhaoliang ^a,b   Cooper, Margaret ^a,b   Crockett, David P ^b   Zhou, Renping ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Axon tracing; Striatum; Substantia nigra; Ventral tegmental area

Indexed keywords

DOPAMINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN DEVELOPMENT; BRAIN REGION; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG DEPENDENCE; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; ISOTOPE LABELING; LIMBIC CORTEX; MESENCEPHALON; MOUSE; NERVE CELL DIFFERENTIATION; NERVE FIBER; NONHUMAN; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; SCHIZOPHRENIA; SUBSTANTIA NIGRA; THALAMUS VENTRAL NUCLEUS; VENTRAL TEGMENTUM;

AGING; ANIMALS; AXONAL TRANSPORT; CAUDATE NUCLEUS; CELL DIFFERENTIATION; DOPAMINE; FEMALE; FLUORESCENT DYES; MESENCEPHALON; MICE; MICE, INBRED STRAINS; NEOSTRIATUM; NEURAL PATHWAYS; NEURONS; PREGNANCY; PUTAMEN; SUBSTANTIA NIGRA; VENTRAL TEGMENTAL AREA;

EID: 3843119924     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20230     Document Type: Article

References (39)

1. Arenas E. 2002. Stem cells in the treatment of Parkinson's disease. Brain Res Bull 57:795-808.
2. Bagri A, Cheng HJ, Yaron A, Pleasure SJ, Tessier-Lavigne M. 2003. Stereotyped pruning of long hippocampal axon branches triggered by retraction inducers of the semaphorin family. Cell 113:285-299.
3. Barde YA. 1989. Trophic factors and neuronal survival. Neuron 2:1525-1534.
4. Bayer SA, Wills KV, Triarhou LC, Ghetti B. 1995. Time of neuron origin and gradients of neurogenesis in midbrain dopaminergic neurons in the mouse. Exp Brain Res 105:191-199.
5. Beckstead RM, Domesick VB, Nauta WJ. 1979. Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res 175:191-217.
6. Brambilla R, Schnapp A, Casagranda F, Labrador JP, Bergemann AD, Flanagan JG, Pasquale EB, Klein R. 1995. Membrane-bound LERK2 ligand can signal through three different Eph-related receptor tyrosine kinases. EMBO J 14:3116-3126.
7. Carter DA, Fibiger HC. 1977. Ascending projections of presumed dopamine-containing neurons in the ventral tegmentum of the rat as demonstrated by horseradish peroxidase. Neuroscience 2:569-576.
8. Clarke PG, Posada A, Primi MP, Castagne V. 1998. Neuronal death in the central nervous system during development. Biomed Pharmacother 52:356-362.
9. Dahlstrom A, Fuxe K. 1964. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamine in the cell bodies of brainstem neurons. Acta Physiol Scand 232(Suppl):1-55.
10. Di Chiara G, Morelli M, Acquas E, Carboni E. 1992. Functions of dopamine in the extrapyramidal and limbic systems. Clues for the mechanism of drug actions. Arzneimittelforschung 42:231-237.
11. Fallon JH, Loughlin SE. 1982. Monoamine innervation of the forebrain: collateralization. Brain Res Bull 9:295-307.
12. Fallon JH, Moore RY. 1978. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol 180:545-580.
13. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S. 2001. Transplantation of embryonic dopamine neurons for severe Parkinson's disease [comment]. N Engl J Med 344:710-719.
14. Gao PP, Yue Y, Cerretti DP, Dreyfus C, Zhou R. 1999. Ephrin-dependent growth and pruning of hippocampal axons. Proc Natl Acad Sci U S A 96:4073-4077.
15. Heimer L, Zahm DS, Alheid GF. 1995. Basal ganglia. In: Paxinos G, editor. The rat nervous system. San Diego: Academic Press.
16. Hyman SE. 1996. Addiction to cocaine and amphetamine. Neuron 16:901-904.
17. Ikai Y, Takada M, Mizuno N. 1994. Single neurons in the ventral tegmental area that project to both the cerebral and cerebellar cortical areas by way of axon collaterals. Neuroscience 61:925-934.
18. Jackson-Lewis V, Vila M, Djaldetti R, Guegan C, Liberatore G, Liu J, O'Malley KL, Burke RE, Przedborski S. 2000. Developmental cell death in dopaminergic neurons of the substantia nigra of mice. J Comp Neurol 424:476-488.
19. Jacobowitz DM, Abbott LC. 1997. Atlas of the developing mouse brain. Boca Raton, FL: CRC Press LLC.
20. Kim JH, Auerbach JM, Rodriguez-Gomez JA, Velasco I, Gavin D, Lumelsky N, Lee SH, Nguyen J, Sanchez-Pernaute R, Bankiewicz K, McKay R. 2002. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease [comment]. Nature 418:50-56.
21. Lindvall O, Bjorklund A. 1979. Dopaminergic innervation of the globus pallidus by collaterals from the nigrostriatal pathway. Brain Res 172: 169-173.
22. Lindvall O, Bjorklund A. 1983. Dopamine-norepinephrine-containing neuron system: their anatomy in the rat brain. New York: Raven Press.
23. Ma Y, Feigin A, Dhawan V, Fukuda M, Shi Q, Greene P, Breeze R, Fahn S, Freed C, Eidelberg D. 2002. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann Neurol 52:628-634.
24. Moore RY, Bloom FE. 1978. Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. Annu Rev Neurosci 1:129-169.
25. Nakamura S, Ito Y, Shirasaki R, Murakami F. 2000. Local directional cues control growth polarity of dopaminergic axons along the rostrocaudal axis. J Neurosci 20:4112-4119.
26. Nauta WJ, Smith GP, Faull RL, Domesick VB. 1978. Efferent connections and nigral afferents of the nucleus accumbens septi in the rat. Neuroscience 3:385-401.
27. Oo TF, Burke RE. 1997. The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra. Brain Res Dev Brain Res 98:191-196.
28. Oo TF, Kholodilov N, Burke RE. 2003. Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal glial cell line-derived neurotrophic factor in vivo. J Neurosci 23:5141-5148.
29. Oppenheim RW. 1991. Cell death during development of the nervous system. Annu Rev Neurosci 14:453-501,
30. Self DW, Nestler EJ. 1995. Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci 18:463-495.
31. Simon DK, O'Leary DD. 1990. Limited topographic specificity in the targeting and branching of mammalian retinal axons. Dev Biol 137:125-134.
32. Simon DK, O'Leary DD. 1992. Development of topographic order in the mammalian retinocollicular projection. J Neurosci 12:1212-1232.
33. Simon H, Le Moal M, Galey D, Cardo B. 1976. Silver impregnation of dopaminergic systems after radiofrequency and 6-OHDA lesions of the rat ventral. Brain Res 115:215-231.
34. 3H]leucine and horseradish peroxidase. Brain Res 178:17-40.
35. van der Kooy D. 1979. The organization of the thalamic, nigral and raphe cells projecting to the medial vs lateral caudate-putamen in rat. A fluorescent retrograde double labeling study. Brain Res 169:381-387.
36. Voorn P, Kalsbeek A, Jorritsma-Byham B, Groenewegen HJ. 1988. The pre- and postnatal development of the dopaminergic cell groups in the ventral mesencephalon and the dopaminergic innervation of the striatum of the rat. Neuroscience 25:857-887.
37. Watts RJ, Hoopfer ED, Luo L. 2003. Axon pruning during Drosophila metamorphosis: evidence for local degeneration and requirement of the ubiquitin-proteasome system [comment]. Neuron 38:871-885.
38. Yue Y, Widmer DA, Halladay AK, Cerretti DP, Wagner GC, Dreyer JL, Zhou R. 1999. Specification of distinct dopaminergic neural pathways: roles of the Eph family receptor EphB1 and ligand ephrin-B2. J Neurosci 19:2090-2101.
39. Yuen EC, Howe CL, Li Y, Holtzman DM, Mobley WC. 1996. Nerve growth factor and the neurotrophic factor hypothesis. Brain Dev 18:362-368.